Elias Obeid, MD, MPH
Fox Chase Cancer Center
333 Cottman Ave
Philadelphia, PA 19111-2497
Video: Dr. Obeid
Breast, Ovarian, and Prostate Cancer Risk
2012 Hematology Board Eligible;
2012 Medical Oncology Board Eligible;
2009 Illinois, Medical License
I am a medical oncologist who specializes in the treatment of breast cancer. I completed my fellowship training at the University of Chicago where my focus was on treatment and research related to breast cancer and cancer genetics. I had also special training in clinical cancer genetics and cancer risk assessment.
We live at an exciting time in cancer care where not only novel treatment options are available to patients, but also we have the tools to identify those who are at risk and help prevent cancer or detect it early when therapy can be more effective. At Fox Chase, the importance of cancer prevention has been recognized for decades and cancer prevention research at this institution has helped shape the field of cancer prevention. I joined Fox Chase because as a member of the risk assessment program (RAP) and the breast cancer service line, we work as a team to individualize the care of every one of our patients.
My philosophy in taking care of my patients is to spend as much time in listening to them. This allows me to know exactly what their fears and concerns are. Cancer diagnosis is a tough one, and no one should walk that path alone. Here at Fox Chase, we work as a team in designing the plan of care for our patients and when appropriate for their families if we identified a susceptibility to developing cancer in that family.
When I am not in clinic, I am involved in research that focuses on the interaction between gene and environment and understanding mechanisms of development of breast cancer.
Essentials in Patient-Oriented Research I: Clinical Research Implementation
Essentials in Patient-Oriented Research II: Statistical Methods in Clinical Research, 2013;
Intensive Course in Comprehensive Cancer Risk Assessment, City of Hope, Los Angeles, CA, 2011-2012;
MA, Public Health, University of Massachusetts, Amherst, MA, 2006-2010;
MD, American University of Beirut School of Medicine, Beirut, Lebanon, 1996-2000
FellowshipsClinical Fellow, Section of Hematology/Oncology, University of Chicago Medical Center, Chicago, IL, 2009-2012;
Research Fellow, Section of Hematology/Oncology, Olopade Lab, University of Chicago, Chicago, IL, 2012
Honors and Awards
2012 The Abbott-Gonzalez Research Fellow Award, University of Chicago;
2008 American College of Physicians - Connecticut (ACP-CT) Award for Volunteerism/Judge Research Awards;
2008 1st Annual Award: Service for Mission, Hospital of Saint Raphael, New Haven, CT
Professional SocietiesAmerican College of Physicians (Fellow);
Honor Society of Phi Kappa Phi;
American Society of Clinical Oncology;
American Society of Hematology;
American Association for Cancer Research (AACR)
Obeid E, Nanda R, Fu YX, Olopade O. The Role of Tumor Associated Macrophages in Breast Cancer Progression.International Journal of Oncology, in press
Obeid E, Conzen SD. The Role of Adrenergic Signaling in Breast Cancer Biology. Cancer Biomarkers, in press.
Melhem-Bertrandt A, Bojadzieva AJ, Ready KJ, Obeid E, Liu DD, Gutierrez-Barrera AM, Litton JK, Olopade OI, Hortobagyi GN, Strong LC, Arun BK. Early Onset HER2-positive Breast Cancer is Associated with Germline TP53 Mutations.Cancer; 118(4):908-13; Feb. 15, 2012
Melhem-Bertrandt A. Obeid E. Editorial: Aspirin Intake and Survival After Breast Cancer: Holmes MD, Chen WY, Li L, et al (Brigham and Women's Hospital and Harvard Medical School, Boston; Dana-Farber Cancer Inst, Boston, MA; Harvard School of Public Health, Boston, MA, J Clin Oncol 28:1467-1472, 2010.
Breast Diseases: A Year Book Quarterly 2011), 22 (4), pg. 355-355, Jan. 2011
Obeid E, Sreih A, (Editor: Kenneth D. Miller, MD). Rheumatic Problems in Cancer Survivors (Book Chapter 27). The Medical and Psychosocial Care of the Cancer Survivor. Jones and Barlett Publishers; 2009